Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
4,761,845
-
Share change
-
+655,845
-
Total reported value
-
$40,598,048
-
Price per share
-
$8.53
-
Number of holders
-
29
-
Value change
-
+$5,791,820
-
Number of buys
-
15
-
Number of sells
-
7
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q2 2018
As of 30 Jun 2018,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,761,845 shares.
The largest 10 holders included
683 Capital Management, LLC, ORBIMED ADVISORS LLC, Ibex Investors LLC, MENORA MIVTACHIM HOLDINGS LTD., Migdal Insurance & Financial Holdings Ltd., Kepos Capital LP, Creative Planning, ARK Investment Management LLC, Candriam Luxembourg S.C.A., and MEITAV DASH INVESTMENTS LTD.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.